Quantcast

Latest liver disease Stories

2014-10-13 08:26:44

SOUTH SAN FRANCISCO, Calif., Oct. 13, 2014 /PRNewswire/ -- Tobira Therapeutics, Inc., a clinical-stage biopharmaceutical company advancing cenicriviroc (CVC) in liver disease and HIV, announced today that it has dosed the first patient in its CENTAUR study of patients with non-alcoholic steatohepatitis (NASH) and liver fibrosis, a disease affecting approximately 3-5 percent of the U.S. population. The initiation of the CENTAUR study follows the completion of a Phase 1 safety study in...

Researchers Identify Epigenetic Changes Caused By Binge Drinking
2014-10-10 03:38:43

Provided by University of Missouri School of Medicine Overconsumption of alcohol triggers inflammatory response in the liver Researchers at the University of Missouri School of Medicine have identified epigenetic protein changes caused by binge drinking, a discovery that could lead to treatments for alcohol-related liver diseases. “We know that chronic alcohol use is damaging to the liver, but binge drinking amplifies that damage,” said Shivendra Shukla, PhD, Margaret Proctor...

2014-09-30 08:31:31

CF102 has shown to induce healthy liver cell proliferation resulting in improved liver status PETACH TIKVA, Israel, Sept. 30, 2014 /PRNewswire/ -- Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer and inflammatory diseases, today announced the United States Patent and Trademark Office has issued a patent to the Company which covers its drug candidate, CF102, in the treatment of...

2014-09-01 23:01:04

Transparency Market Research published a new report "Liver Diseases Therapeutics Market: Global Industry Analysis, Size, Share, Trends and Forecast 2012 - 2018" to its report store. Albany, New York (PRWEB) September 01, 2014 Liver is the largest organ inside the human body. Liver is the one vital organ that helps the body in barring itself from poisons, helps in digestion of food and acts as a store of energy. Liver also plays many important functions such as protein...

2014-07-22 08:32:59

TEL AVIV, Israel, July 22, 2014 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed"), a clinical-stage biopharmaceutical company focused on the development and commercialization of a once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones, announced today that the U.S. Food and Drug Administration, or the FDA, cleared Galmed's Investigational New Drug, or IND, application. Such clearance will permit Galmed to conduct clinical trials of...

2014-07-15 23:10:56

The Fatty Liver Bible & Ezra Protocol review that was just updated by Vkool.com reveals Debra Elkin’s home treatment system that promises efficiency in treating fatty liver and obesity. Seattle, Wa (PRWEB) July 15, 2014 According to the Fatty Liver Bible & Ezra Protocol review recently updated by Vkool.com, this is a helpful guide that provides readers with a wide range of tips and advice on how to resolve fatty liver and obesity. This book consists of 8 chapters including:...

2014-07-08 12:28:47

TEL AVIV, Israel, July 8, 2014 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq:GLMD) ("Galmed") today announced the recent publication of the results of its Phase IIa clinical trial of aramchol in the peer-reviewed Clinical Gastroenterology and Hepatology Journal. The trial manuscript, entitled "The Fatty Acid-Bile Acid Conjugate Aramchol Reduces Liver Fat Content in Patients with Nonalcoholic Fatty Liver Disease," provides the full report of the Phase IIa trial, which was...

2014-06-25 23:08:47

Transparency Market Research has published a new report titled "Global Liver Diseases Therapeutics Market: Industry Analysis, Size, Share, Trends and Forecast 2012 - 2018" to its report store. Browse the full report: http://www.transparencymarketresearch.com/liver-diseases-therapeutics.html. Albany, New York (PRWEB) June 25, 2014 The report on “Liver Diseases Therapeutics Market (Chemotherapy, Anti-Virals, Vaccines, Targeted Therapy And Immunosuppressants) - Global Industry...

2014-06-23 09:37:29

Monash University An international team of scientists led by Monash University researchers has shown how free radicals contribute to type 2 diabetes, obesity and fatty liver disease. Type 2 diabetes and non-alcoholic fatty liver disease are key complications of obesity as 80 per cent of patients with type 2 diabetes are obese, and 75 per cent of patients who are obese or have type 2 diabetes also have fatty liver disease. The team, led by Professor Tony Tiganis from the Department...

2014-06-23 08:29:48

SOUTH SAN FRANCISCO, Calif., June 23, 2014 /PRNewswire/ -- Tobira Therapeutics, a clinical-stage biopharmaceutical company advancing cenicriviroc (CVC) in liver disease and HIV, announced today the appointment of four directors to its Board: Jeffrey H. Cooper, Craig S. Gibbs, Ph.D., Gwen A. Melincoff and Graeme J. Moyle, M.B.B.S., M.D. "I am very pleased to add to our Board of Directors a group of diverse and talented individuals who bring a wealth of experience and unique skill set...


Word of the Day
conjunto
  • A style of popular dance music originating along the border between Texas and Mexico, characterized by the use of accordion, drums, and 12-string bass guitar and traditionally based on polka, waltz, and bolero rhythms.
The word 'conjunto' comes through Spanish, from Latin coniūnctus, past participle of coniungere, to join together; see conjoin